Indeed good news. Not a complete game changer, but will make a difference in 10's of thousands of people's lives.
Based on the report, the mortality rate of remdesivir treated patients were 8.0% vs 11.6% on the placebo.
So if the remdesivir study pans out, this reduces the IFR from 0.87% (see...